Mir Hashim - 09 Sep 2021 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Role
Chief Scientific Officer
Signature
/s/ Josh Seidenfeld, Attorney-in-Fact for Mir Hashim
Issuer symbol
RANI
Transactions as of
09 Sep 2021
Net transactions value
$0
Form type
4
Filing time
13 Sep 2021, 19:53:09 UTC
Previous filing
02 Aug 2021
Next filing
24 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RANI Class A Common Stock Award $0 +117,600 $0.000000 117,600 09 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the restricted stock unit grant vest as follows: 50% of the RSUs shall vest on September 9, 2022, and 50% shall vest on September 9, 2023.